TITAN BIOTECH LTD. Share Price

TITAN BIOTECH LTD. Share Price

BSE: 524717
|
Pharmaceuticals
|
S Cap
₹ 399.50
-₹0.05 (-0.01%)
1D
Last updated 23 Sep, 2026, 15:29 IST

TITAN BIOTECH LTD. Share Price Today

As of 24 Sep 2026, TITAN BIOTECH LTD. share price is ₹399.50. The stock opened at ₹400.00, compared to its previous close of ₹399.55. During today's trading session, TITAN BIOTECH LTD. share price moved in the range of ₹390.00 to ₹409.95, with an average price of ₹399.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹171.40 and a high of ₹555.65.

₹390.00
0.01% down today
₹409.95
1D LOW
1D HIGH

TITAN BIOTECH LTD. Returns Calculator

Circuit
L
H
₹379.60
₹419.50
52-week
L
H
₹171.40
₹555.65

About TITAN BIOTECH LTD.

TITAN BIOTECH LTD. Share Price
ISIN
INE150C01029
Sector Market Cap
₹ 1,650.88 Cr

Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.

TITAN BIOTECH LTD. Financial Highlights

  • Revenue: TITAN BIOTECH LTD. reported revenue of ₹211.60 crore in FY26 vs ₹160.36 crore in FY25. It showed an increase of 31.95% on a yearly basis.
  • Operating Profit: TITAN BIOTECH LTD. reported an operating profit of ₹38.17 crore in FY26 vs ₹24.37 crore in FY25. It showed an increase of 56.63% on a year-on-year basis.
  • Net Profit: TITAN BIOTECH LTD. reported a net profit of ₹27.45 crore in FY26 vs ₹18.27 crore in FY25. It showed an increase of 50.25% on a yearly basis.

TITAN BIOTECH LTD. Quarterly Result Highlights

  • TITAN BIOTECH LTD. reported revenue of ₹60.98 crore in Jun 2026, compared with ₹50.94 crore in Mar 2026, representing an increase of 19.71% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported an operating profit of ₹12.73 crore in Jun 2026, compared with ₹10.28 crore in Mar 2026, representing an increase of 23.83% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported a profit of ₹9.46 crore in Jun 2026, compared with ₹6.56 crore in Mar 2026, reflecting an increase of 44.21% on a QoQ basis.
  • The earnings per share (EPS) of TITAN BIOTECH LTD. stood at ₹26.06 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
55.78%
FII
0.00%
Other DII
0.01%
Retail and other
44.21%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
1,650.88
P/E
48.53
P/B
9.06
ROE
16.46%
D/E
0.03
ROCE
20.87%
Div. Yield
0.13%
EPS(TTM)
6.64
Turnover
1.08
EV/EBITDA
33.87
Net Margin
0.00%
Op. Margin
0.00%
ROA
14.38%
Quick Ratio
0.00
Curr. Ratio
3.87
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Titan Biotech outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Titan Biotech appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Titan Biotech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TITAN BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹156.45₹164.07₹144.00₹123.55
Other Income₹3.91₹1.75₹1.94₹0.94
Total Revenue₹160.36₹165.82₹145.94₹124.49
Total Expenses₹136.00₹134.29₹117.83₹95.52
Profit Before Tax₹24.37₹31.53₹28.12₹28.97
Tax₹6.10₹7.87₹7.09₹7.28
Profit After Tax₹18.27₹23.66₹21.02₹21.68
EPS - Basic₹26.06₹30.07₹30.06₹26.24
EPS - Diluted₹26.06₹30.07₹30.06₹26.24

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹24.37₹31.53₹28.12₹28.97
Income before WC changes₹29.66₹36.29₹31.64₹32.49
Change in Assets-₹6.34-₹5.77-₹6.27-₹5.82
Change in Liabilities₹2.80-₹1.51₹3.31₹2.49
Change in WC-₹3.55-₹7.28-₹2.96-₹3.33
Cash flow from Operations₹20.12₹21.15₹21.18₹22.04
Cash flow from Investing-₹9.87-₹20.30-₹20.73-₹16.44
Cash flow from Financing-₹7.96-₹2.87-₹2.40-₹4.10
Total Cash Flow₹2.29-₹2.02-₹1.95₹1.51
Cash (Start of the year)₹2.84₹4.86₹6.81₹5.31
Cash (End of the year)₹5.13₹2.84₹4.86₹6.81

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹95.67₹84.41₹66.21₹44.34
Current Assets₹79.04₹72.62₹68.31₹63.76
Total Assets₹174.71₹157.03₹134.52₹108.09
Current Liabilities₹17.74₹19.57₹20.35₹16.95
Net Current Asset₹61.30₹53.05₹47.96₹46.81
Non-Current Liabilities₹3.57₹4.00₹4.25₹4.90
Equity Capital₹153.40₹133.45₹109.91₹86.24
Total Equity & Liabilities₹174.71₹157.03₹134.52₹108.09

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹156.45₹164.07₹144.00₹123.55
Other Income₹3.91₹1.75₹1.94₹0.94
Total Revenue₹160.36₹165.82₹145.94₹124.49
Total Expenses₹136.00₹134.29₹117.83₹95.52
Profit Before Tax₹24.37₹31.53₹28.12₹28.97
Tax₹6.10₹7.87₹7.09₹7.28
Profit After Tax₹18.27₹23.66₹21.02₹21.68
EPS - Basic₹22.11₹28.64₹25.44₹26.24
EPS - Diluted₹22.11₹28.64₹25.44₹26.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹24.37₹31.53₹28.12₹28.97
Income before WC changes₹29.66₹36.29₹31.64₹32.49
Change in Assets-₹6.34-₹5.77-₹6.27-₹5.82
Change in Liabilities₹2.80-₹1.51₹3.31₹2.49
Change in WC-₹3.55-₹7.28-₹2.96-₹3.33
Cash flow from Operations₹20.12₹21.15₹21.18₹22.04
Cash flow from Investing-₹9.87-₹20.30-₹20.73-₹16.44
Cash flow from Financing-₹7.96-₹2.87-₹2.40-₹4.10
Total Cash Flow₹2.29-₹2.02-₹1.95₹1.51
Cash (Start of the year)₹2.84₹4.86₹6.81₹5.31
Cash (End of the year)₹5.13₹2.84₹4.86₹6.81

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹87.40₹79.40₹62.39₹44.34
Current Assets₹79.04₹72.17₹68.31₹63.76
Total Assets₹166.44₹151.57₹130.70₹108.09
Current Liabilities₹17.74₹19.13₹20.35₹16.95
Net Current Asset₹61.30₹53.05₹47.96₹46.81
Non-Current Liabilities₹3.57₹4.00₹4.25₹4.90
Equity Capital₹145.13₹128.44₹106.09₹86.24
Total Equity & Liabilities₹166.44₹151.57₹130.70₹108.09
* All values are in INR Crore
Qty
Bid
38
398.2
10
398.1
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 48
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
46.1
Neutral
ATR (14)
22.74
Neutral
STOCH(9,6)
17.92
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
15.27
Bullish
UO(9)
44.06
Neutral
ROC(12)
-7.96
Bearish
WillR(14)
-82.08
Bullish
Period
Simple value
Exponential vaue
5D
404.41
404.56
10D
413.66
408
20D
407.46
408.19
50D
408.57
408.67
100D
420.65
401.8
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
TITAN BIOTECH LTD. Share Price
TITAN BIOTECH LTD.
Pharmaceuticals
Add Stock
Add Another

TITAN BIOTECH LTD. Share Price FAQs

TITAN BIOTECH LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837